NTCELL for Parkinson’s disease
The Phase I clinical trial is underway and we expect the first patient to be consented into the trial in
the next fortnight.
Following consent, the patient will be monitored for eight weeks to establish baseline data, with the
implant expected to occur during Q3.
If the product is shown to be effective in humans, registration in 2018/2019 via a fast-tracked
development programme should be achievable. However, the development programme is at an early
stage and this target registration date may change, depending on the results of the Phase I and
subsequent trials.
Their greed prevents them from caring about the many blighted lives. I hope to God I am wrong.
GG
X
The Phase I/IIa NTCELL clinical trial in New Zealand for the treatment of Parkinson’s disease met the primary endpoint of safety and showed encouraging clinical efficacy improvements. Results from this trial will be used to design a larger registration-enabling Phase IIb trial to evaluate its potential as a disease-modifying treatment for patients with Parkinson’s disease. It has the potential to be used in a number of other central nervous system indications such as Huntington’s, Alzheimer’s and motor neurone diseases.
th time try blue tinted glasses for me the effect has been truly amazing stopped disky and depression even severe migraine and nosebleed ,its true I tell you ys yes its true,see article on UTOOB, has not fixed this toplaps errant mizzzpillieen section, I cure have a ne meawaiting and if it dont ficksitsellf a syrinege of ketameeeeeeeeen awaits
Kind Regards old friend FED
In
you have success with blue tinted glasses?
very interesting.
here is something else
http://www.medscape.com/viewarticle/847165
may sort serotonin based psychosis - eg hallucinations something i strongly expect i will require in next two years or less and i know you have trouble with now.
but nosebleeds? thats a new symptom i've never heard of